Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: A Pediatric Blood and Marrow Transplant Consortium study
- 1 September 2003
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 32 (6), 543-548
- https://doi.org/10.1038/sj.bmt.1704198
Abstract
Conditioning regimens for children with ALL have generally included total body irradation (TBI), which may result in significant sequelae. The primary aim of this study was to evaluate the outcome for children with ALL undergoing allogeneic stem cell transplant (SCT) with either busulfan (Bu) or TBI regimens. Patients P=0.03). There was no significant difference between Bu and TBI for patients who received stem cells from related donors (36 vs 58%, P=0.3). However, for URD, EFS was 20% for Bu and 57% for TBI (P=0.04). Relapses were similar in both arms. This randomized prospective study suggests that Bu is inferior to TBI for pediatric patients with ALL undergoing allogeneic SCT.Keywords
This publication has 30 references indexed in Scilit:
- Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): A phase I study of the pediatric blood and marrow transplant consortiumMedical and Pediatric Oncology, 2000
- Busulfan pharmacokinetics do not predict relapse in acute myeloid leukemiaBone Marrow Transplantation, 2000
- Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphomaBone Marrow Transplantation, 2000
- Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamideBone Marrow Transplantation, 2000
- Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimenBone Marrow Transplantation, 1998
- Solid Cancers after Bone Marrow TransplantationNew England Journal of Medicine, 1997
- Growth in Children Undergoing Bone Marrow Transplantation After Busulfan and Cyclophosphamide ConditioningJournal of Pediatric Hematology/Oncology, 1996
- A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemiaBritish Journal of Haematology, 1996
- A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation GroupBlood, 1994
- Graft-versus-host disease: pathophysiological and clinical aspects.Annual Review of Medicine, 1984